Genexa Launches Clean Line of Kids’ Medicine in Whole Foods Market

Parents Can Now Purchase Genexa’s Effective Over-the-Counter Medicines at Whole Foods Market

As the impending cold and flu season draws near, Genexa proudly announces the debut of its highly acclaimed clean, and effective, line of over-the-counter (OTC) children’s medicines at Whole Foods Market stores. Genexa Kids’ Pain & Fever (acetaminophen), Kids’ Allergy (diphenhydramine), and Kids’ Tummy Relief (calcium carbonate) medicines will be available at Whole Foods Markets Stores nationwide and provide parents with OTC options that comply with Genexa’s stringent ingredient standards that ban many ingredients commonly found in other OTCs. In addition, most products are certified vegan and all are certified gluten-free.

“As confirmation of all that Genexa has accomplished, we are proud to be able to share that we have been awarded a patent for our Kids’ and Infants’ Pain & Fever liquid acetaminophen formulation. And, we are also so proud to have our OTC products on shelf at Whole Foods,” said Genexa CEO David Johnson.

Genexa Kids’ Pain & Fever is an oral suspension for kids ages 2-11. The patented formula is available in two flavors—blueberry and cherry. It’s sweetened with agave syrup, resulting in no medicine after-taste. For kids who don’t like taking liquid medicine, Kids’ Pain & Fever Chewable is another option. The chewable tablets come in a tasty grape flavor.

Arriving just in time at Whole Foods Market for the holidays, Kids’ Tummy Relief for ages 2+ provides the same 400mg of calcium carbonate per tablet as Pepto Bismol® Kids Chewable Tablets Bubblegum. The chewable tablets offer soothing relief from heartburn, acid indigestion, and upset stomach and come in delicious berry and vanilla flavors that meet Genexa’s stringent ingredient standards.

Genexa’s best-selling Kids’ Allergy for ages 6+ contains the same 12.5mg of diphenhydramine HCl per 5mL as Children’s BENADRYL® Allergy Liquid Cherry. This product is flavored with soothing agave syrup and provides temporary relief from common allergy symptoms.

In addition to the children’s line, Whole Foods Market also carries Genexa’s adult pain relievers Acetaminophen Extra Strength and Acetaminophen PM. Acetaminophen Extra Strength is the first clean adult pain reliever with the same 500mg of acetaminophen per caplet as TYLENOL® Extra Strength Caplets, but without ingredients like titanium dioxide, although deemed safe by the FDA, that don’t meet Genexa’s stringent ingredient standards. Unlike most adult acetaminophen options currently available, Acetaminophen Extra Strength is certified vegan.

As a Certified B-Corporation, Genexa is committed to using business as a force for good, meeting rigorous standards of social and environmental performance, accountability, and transparency. For more information, visit Genexa.com.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.